Cookie Policy

By clicking "Accept", you are agreeing to continue browsing and accept the website privacy policy.

Responsive image

Drug Information

Drug Generic Name OXYBUTYNIN HYDROCHLORIDE
Drug Class DRUGS USED IN URINARY TRACT DISORDERS
Chapter Obstetrics, Gynaecology & Urinary Tract Disorders

Indications: urinary frequency, urgency and incontinence and nocturnal enuresis, in bladder dysfunction, especially in the elderly; uninhibited vesical hyperactivity after bladder surgery, prostatectomy and in association with acute and chronic cystitis. neurogenic bladder instability, and nocturnal enuresis associated with overactive bladder

Cautions: pregnancy, children less than 5 years of age; ulcerative colitis, toxic megacolon autonomic neuropathy, severe heart disease, porphyria, renal or hepatic disease.

Contra-indications: ileostomy, colostomy; glaucoma, myasthenia gravis.

Side Effects: anticholinergic side effects may occur as dry mouth, blurred vision, decreased sweating, drowsiness, tachycardia, palpitations, urinary retention and constipation. Allergic skin reactions may occur.

Dizziness; less commonly anorexia, facial flushing; rarely night terrors; application site reactions with patches.

Dose: adults, by mouth initially 2.5–5mg 2–3 times daily increased if necessary to max. 5mg 4 times daily; elderly initially 2.5–3mg twice daily, increased to 5mg twice daily according to response and tolerance.

Child over 5 year, neurogenic bladder instability, 2.5mg - 3mg twice daily increased to 5mg twice daily; max. dose is 5mg 3times daily.

Nocturnal enuresis in child over 7 days, 2.5 - 3mg twice daily increased to 5mg 2-3 times daily (last dose before bedtime).

Pregnancy: avoid unless benefit outweighs risk.

Breast feeding: Present in milk- advise to avoid

Brand Name
  • Cystrin Tablets 5mg
rating - 1 starrating - 2 starrating - 3 starrating - 4 starrating - 5 star